The network map of mucin 1 mediated signaling in cancer progression and immune modulation
Abstract Mucin 1 (MUC1) is a type-I transmembrane glycoprotein, ranked as the second most promising cancer antigen for therapeutic development by the National Cancer Institute. Recently, MUC1 has gained significant attention as a therapeutic target in cancer immunotherapy. Thus, understanding MUC1-r...
Saved in:
| Main Authors: | Akhina Palollathil, Shobha Dagamajalu, Mukhtar Ahmed, Manavalan Vijayakumar, Thottethodi Subrahmanya Keshava Prasad, Rajesh Raju |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03030-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An assembled molecular signaling map of interleukin-24: a resource to decipher its multifunctional immunoregulatory role in pathophysiological conditions
by: Anjana Aravind, et al.
Published: (2025-06-01) -
Mapping growth differentiation factor-15 (GDF15)-mediated signaling pathways in cancer: insights into its role across different cancer types
by: Akhila Balakrishna Rai, et al.
Published: (2025-03-01) -
HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers
by: Akhina Palollathil, et al.
Published: (2024-10-01) -
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01) -
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma
by: Daniela Lorizio, et al.
Published: (2025-06-01)